Navivumab

Tax included
Navivumab (CT-P23) is an influenza A virus hemagglutinin HA monoclonal antibody. neutralizes H1, H2, H5, and H9 influenza A viruses by binding to the stem fusion domain in HA2.
MedChemExpress 
HY-P99750

Data sheet

Size
Multiple sizes
Reactivity
Influenza Virus
CAS
1443004-16-7